Magdalena Kosch
Content manager at alpha Technik GmbH & Co. KG at alpha Technik GmbH & Co. KG- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
Englisch -
-
Deutsch -
-
Russisch Elementary proficiency
Topline Score
Bio
Experience
-
alpha Technik GmbH & Co. KG
-
Germany
-
Motor Vehicle Manufacturing
-
1 - 100 Employee
-
Content manager at alpha Technik GmbH & Co. KG
-
Apr 2019 - Present
Concept/development, design and implementation of communication measures, print and online media for products, campaigns and social media.- content management: print media, newsletters, product presentation, advertising, social media- video and image creation- project development and implementation (customer events, trade fairs)- data maintenance (website / online store) Concept/development, design and implementation of communication measures, print and online media for products, campaigns and social media.- content management: print media, newsletters, product presentation, advertising, social media- video and image creation- project development and implementation (customer events, trade fairs)- data maintenance (website / online store)
-
-
-
concentris research management GmbH
-
Germany
-
Research Services
-
1 - 100 Employee
-
Projektmanager
-
Mar 2013 - Mar 2019
Daily management of EU- and IMI(2)-funded projects. Coordination of proposal writing and submission for EU- and IMI2 (public private partnership) funded projects. Contractual management for Consortium Agreements and Grant Agreements. Active involvement in communication and dissemination activities. International meeting and conference organisation.Managed projects:- European Medical Information Framework (EMIF) – EMIF was a public-private consortium partnership of 58 teams from academia, small and medium sized companies and members of the European Federation of Pharmaceutical Industries and Associations (EFPIA) and ran for 5.5 years, ending June 2018. During this time span, EMIF has successfully improved access to human health data via providing tools and workflows to discover, assess, access and (re)use human health data. Coordinators: Bart Vannieuwenhuyse, Janssen Pharmaceutica as overall Project Coordinator; Sir Simon Lovestone, University of Oxford as overall Project Co-Coordinator.- stemBANCC (Stem cells for Biological Assays of Novel drugs and prediCtive toxicology) - Coordinator: Martin Graf, F. Hoffmann-La Roche; Managing Entity: Dr. Zameel Cader, University of Oxford; funding scheme: IMI, collaborative project, 35 partners; duration: 60 months (started October 2012)- REPO-TRIAL (Improving the efficacy and precision of drug REPurpOsing TRIALs) - funding scheme: Horizon2020, 9 partners; duration: 66 months (started February 2018)- MATRICS (Multidisciplinary Approaches to Translational Research In Conduct Syndromes) - funding scheme: FP7, collaborative project, 19 partners; duration: 60 months (started March 2014)- Aggressotype (Aggression subtyping for improved insight and treatment innovation in psychiatric disorders) - funding scheme: FP7, collaborative project, 23 partners; duration: 60 months (started November 2013)
-
-
Education
-
Universität Passau
Bachelor of Arts - BA, European Studies -
International Baccalaureate
Bilingual Diploma